Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

Exonate cleared to begin phase Ib/II evaluation of EXN-407 for diabetic macular edema

Oct. 16, 2020

Tarsus announces data from phase II studies of TP-03 in Demodex blepharitis

Oct. 8, 2020

Kodiak Sciences begins pivotal studies of KSI-301 in DME and RVO

Oct. 6, 2020

Tarsius reports phase I/II data on TRS-01 in active noninfectious anterior uveitis

Oct. 6, 2020

FDA accepts IND for phase IIb study of AR-15512 in dry eye disease

Sep. 30, 2020

FDA clears IND for phase I trial of Emmecell's EO-2002 for corneal edema

Sep. 25, 2020

KITE study of Beovu in DME meets primary and key secondary endpoints

Sep. 14, 2020

Gemini begins phase IIa study of GEM-103 for dry AMD

Sep. 14, 2020

Daiichi Sankyo describes new cytochrome P450 CYP26A1 inhibitors

Sep. 10, 2020

Development of BI-1467335 discontinued for diabetic retinopathy

Sep. 8, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 28, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...